Publisher: John Wiley & Sons Inc
E-ISSN: 1099-1069|36|1|376-378
ISSN: 0278-0232
Source: Hematological Oncology (Electronic), Vol.36, Iss.1, 2018-02, pp. : 376-378
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
Patients with relapsed or refractory mantle cell lymphoma may receive benefit from bortezomib
Inpharma, Vol. 1, Iss. 1544, 2006-01 ,pp. :